Control group:Conventional treatment + placebo

4 trials

Sponsors

Oriental Hospital, Beijing University of Chinese Medicine, Beijing University of Chinese Medicine Dongzhimen Hospital, Dongzhimen Hospital, Beijing University of Chinese Medicine

Conditions

Post-percutaneous coronary intervention (PCI) for acute myocardial infarctioncoronary heart diseaseheart failure with preserved ejection fraction

Phase 4

Clinical Observation of Shengui Capsule Intervention in Heart Failure with Preserved Ejection Fraction

Active, not recruitingITMCTR2200005794

Dongzhimen Hospital, Beijing University of Chinese Medicineheart failure with preserved ejection fraction

Start: 2022-04-06Updated: 2023-02-20

The efficacy and mechanism of Shexiang Tongxin Drop Pills in the treatment of perioperative patients with acute myocardial infarction undergoing percutaneous coronary intervention (PCI).

RecruitingChiCTR2300075069

Beijing University of Chinese Medicine Dongzhimen HospitalPost-percutaneous coronary intervention (PCI) for acute myocardial infarction

Start: 2023-08-31Updated: 2023-08-28

Unknown Phase

Yi-Qi Liang-Xue Sheng-Ji party in the prevention and treatment of cardiavascular events of post-intervention of coronary heart disease (CHD): prospective, multicenter, randomized, double-blind, parallel placebo controlled trial

RecruitingITMCTR2000003081

Oriental Hospital, Beijing University of Chinese Medicinecoronary heart disease

Start: 2020-05-01Updated: 2023-02-20

Yi-Qi Liang-Xue Sheng-Ji party in the prevention and treatment of cardiavascular events of post-intervention of coronary heart disease (CHD): prospective, multicenter, randomized, double-blind, parallel placebo controlled trial

RecruitingChiCTR2000030495

Oriental Hospital, Beijing University of Chinese Medicinecoronary heart disease

Start: 2020-05-01Updated: 2020-03-16